Clinical trial
Control:Diabetes - a Mobile App to Improve Glycemic Control in Patients With Diabetes
NCT04158921 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Control:Diabetes - a Mobile App to Improve Glycemic Control in Patients With Diabetes
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 7, 2019
- Completion date
- July 20, 2022
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 1, insulin treated type 2 diabetes mellitus